Comment from Anonymous
AnonymousSupportIndividual
Summary: A medical doctor provides information on the potential for repurposing anti-CD38 drugs, specifically daratumumab and isatuximab, to treat ME/CFS and Long Covid. The commenter highlights successful pilot study results and argues that these drugs are exciting prospects for repurposing due to their efficacy in other conditions and the high prevalence of these chronic diseases.
Please see attached submission